They found that one drop of low-dose atropine (0.01%–0.1%) “produced clear changes in pupil size and focusing ability that ...
According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
Data presented at ARVO 2026 show that high-dose gene therapy boosts central retinal sensitivity in X-linked retinitis ...
Ariel Ong, a fellow from University College London, discussed her ARVO poster, looking at her work on developing a scalable ...
Paired ocular–systemic measurements in 24 healthy adults revealed OPP as a stronger correlate of GLS and sPAP than either BP ...
Madhura Tamhankar, MD, took some time at the ARVO conference in Denver, Colorado, to discuss disease progression in thyroid ...
Safety signals with faricimab in routine practice, including intraocular inflammation and endophthalmitis, aligned with prior ...
Renee Long, from the University of California San Diego, took some time to discuss her poster on the viability of Grok as a ...
Kaden Bunch, a fourth-year medical student from the Warren Alpert Medical School of Brown University, talked about his poster ...
Ariel Ong, a fellow from University College London, discussed her ARVO poster, looking at her work on developing a scalable pipeline for data extraction from ophthalmic clinical letters and what ...
Immediate past president of ARVO, Srinivas Sadda, MD, FARVO, reflected on the impact the organization has had on his career.
At this year's ARVO meeting in Denver, Colorado, Giulia Corradetti spoke on how baseline OCT biomarkers can predict anatomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results